Lord, Abbett & Co
ALPN

Lord, Abbett & Co’s Alpine Immune Sciences Inc ALPN Stock Holding History

Lord, Abbett & Co’s Portfolio ALPN Stock Details ALPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-64,654
Closed -$3.35M – 963
2015
Q3 		$3.35M Buy
64,654
+4,450
+7% +$292K 0.01% 798
2015
Q2 		$3.65M Buy
+60,204
New +$3.59M 0.01% 812

Other funds holding ALPN

DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
TM
Tiger Management New York $22.8M AUM 0.71% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return

Lord, Abbett & Co's ALPN Position: Q4 2015 in Review

Lord, Abbett & Co sold out of Alpine Immune Sciences Inc (ALPN) in Q4 2015, closing a stake of 64,654 shares — an estimated $3.35M sold.

Lord, Abbett & Co first reported a position in ALPN in Q2 2015 and held it in 2 quarters. The position peaked at $3.65M in Q2 2015. 59 funds tracked by Wall St. Rank hold ALPN as of Q4 2015.

  • Lord, Abbett & Co reported no remaining Alpine Immune Sciences Inc position as of Q4 2015 after selling out during the quarter.
  • Lord, Abbett & Co sold 64,654 Alpine Immune Sciences Inc shares in Q4 2015, an estimated $3.35M.
  • Lord, Abbett & Co first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 2 quarters.
  • Lord, Abbett & Co's Alpine Immune Sciences Inc position peaked at $3.65M in Q2 2015.
  • 59 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q4 2015.

Based on Lord, Abbett & Co's 13F filing for Q4 2015, filed 16 Feb 2016.